Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

FDA recalls thousands of blood pressure bottles, says pills failed quality tests

4 November 2026 · By · Wire by Fusion42

Published

4 November 2026

Topic

regulatory

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at wmur.com →

◆ Verified

Fusion42 · 4 November 2026 · Fusion42 review

The U.S. FDA has issued a nationwide recall for thousands of bottles of blood pressure medication produced by Macleods Pharma USA after the pills failed quality tests.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

Your blood pressure medication supply chain faces new scrutiny and potential disruption following this recall. Now is the moment to review your quality assurance protocols and supplier reliability to avoid similar setbacks.

◆ Coverage

1 source · 4 Nov 2026

◆ Related on Wire

◆ Topics

Healthfdadrug-recallquality-controlblood-pressurepharma